Sartorius Stedim Biotech S.A. (EPA: DIM)

Market Cap	18.06B
Revenue (ttm)	2.74B
Net Income (ttm)	160.60M
Shares Out	97.31M
EPS (ttm)	1.68
PE Ratio	110.34
Forward PE	45.22
Dividend	0.69 (0.38%)
Ex-Dividend Date	n/a

Volume	85,006
Open	180.60
Previous Close	183.30
Day's Range	177.55 - 194.25
52-Week Range	139.10 - 281.00
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 17, 2024

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management servic...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 10,662
• Stock Exchange: Euronext Paris
• Ticker Symbol: DIM

Financial Performance

In 2023, Sartorius Stedim Biotech's revenue was 2.78 billion, a decrease of -20.53% compared to the previous year's 3.49 billion. Earnings were 309.70 million, a decrease of -64.65%.